Skip to main content

Journey Medical Corp

DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867066

No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Journey Medical Corp changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of DERM: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders5668+12
Shares6.49M8.69M+2.20M (+33.9%)
Value$46.6M$61.9M+$15.3M (+32.8%)

New holders (17)

Institutions that held Journey Medical Corp at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to DERM in Q3 2025
InstitutionSharesValue% of portfolio
Summit Financial, LLC379,829$2.70M0.04%
Sheets Smith Investment Management132,904$946.3K0.61%
AQR Capital Management LLC50,834$361.9K0.00%
State of Wisconsin Investment Board35,838$255.2K0.00%
Goldman Sachs Group Inc34,053$242.5K0.00%
Walleye Capital LLC22,554$160.6K0.00%
Occudo Quantitative Strategies LP15,470$110.1K0.01%
SJS Investment Consulting Inc.15,000$106.8K0.01%
Citadel Advisors LLC14,390$102.5K0.00%
Jump Financial, LLC13,810$98.3K0.00%
Salem Investment Counselors Inc12,100$86.2K0.00%
Kestra Advisory Services, LLC10,209$72.7K0.00%
Russell Investments Group, Ltd.8,572$61.0K0.00%
GAMMA Investing LLC164$1.17K0.00%
SRS Capital Advisors, Inc.46$3270.00%
FMR LLC19$1350.00%
CWM, LLC18$00.00%

Sold out (5)

Institutions that held Journey Medical Corp at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of DERM in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Susquehanna International Group, LLP15,388$110.5K
Quadrature Capital Ltd13,181$94.4K
Deutsche Bank AG12,968$93.1K
Cetera Investment Advisers10,731$77.0K
Raymond James Financial Inc5,000$35.9K